Abstract: A folding device of a power scooter includes a base which includes a front portion and a rear portion. Two folding units are located on two sides of the base and pivotably connected between the front portion and the rear portion. The rear wheel unit is driven by a motor and moves toward the front wheel unit of the scooter to fold the front and rear portions.

Abstract: A podiatry assist device for use with a patient in a wheelchair. While the patient remains in the wheelchair, the device supports at least one of the patient's lower extremities as the patient is examined and/or treated. The device includes a pad, a height adjustment mechanism, and a base. At least one of the patient's lower extremities is placed upon and supported by the pad. The height adjustment mechanism is coupled to the pad and operable to raise and lower the pad with respect to the floor. The base is coupled to the height adjustment mechanism and operable to support both the height adjustment mechanism and the pad. Optionally, the device may include a tray.

Abstract: An operating table and a method for an operating table are disclosed. The operating table has an adjustable component, a drive device that adjusts the adjustable component, and a first sensor that detects a position of the adjustable component. The operating table also has a second sensor that detects the position of the adjustable component and a controller that controls the drive device. The controller operates in a first operating mode and a second operating mode. In the first operating mode of the controller, the first sensor is activated and the drive device is energized. in the second operating mode of the controller, the second sensor is activated and the drive device is de-energized The controller changes from the second operating mode to the first operating mode when the second sensor detects a change of the position of the adjustable component.

Abstract: A method of transferring a patient from a first resting surface to a second resting surface includes inserting a corrugated sheet into a channel formed between the patient and the first resting surface, extending a portion of the sheet between the patient and the first resting surface to under the patient's feet, extending a portion of the sheet between the patient and the first resting surface to under the patient's head, and pulling laterally on the sheet to slide the sheet from the first resting surface to the second resting surface thereby transferring the patient.

Abstract: A patient transfer device for transferring a patient resting on a sheet from a first resting device to a second resting device.

Abstract: A patient transfer system includes a patient transfer assembly and a patient transfer device. The assembly includes a sheet of corrugatable material, at least one stiffener that resists corrugation of the sheet in a first dimension when the patient transfer assembly including the sheet corrugated in a second dimension is inserted between the patient and a surface of a first resting device on which the patient rests. The sheet includes portions at which pulling in a direction along the second dimension decorrugates the sheet between the patient and the surface and fasteners. The device includes a sheet engaging assembly that pulls at least one of the fasteners in a direction along the first dimension to slide the decorrugated sheet relative to the surface thereby transferring the patient.

Abstract: A method of transferring a patient from a first resting surface to a second resting surface includes inserting a corrugated sheet into a channel formed between the patient and the first resting surface, extending a portion of the sheet between the patient and the first resting surface to under the patient's feet, extending a portion of the sheet between the patient and the first resting surface to under the patient's head, and pulling laterally on the sheet to slide the sheet from the first resting surface to the second resting surface thereby transferring the patient.

Abstract: A device for supporting a patient to allow an exam to be performed on the patient's breast, including a supporting table which has a longitudinal axis of extension and on which the patient can lie in a reclining position; the supporting table is provided, in proximity to one end of it, with a through hole for receiving the breast to be examined; a mounting frame for mounting the supporting table and equipped with at least one actuator for adjusting the supporting table in height; the supporting table is divided into a first portion and second portion along an axis; the first portion is smaller in extension along the longitudinal axis than the second portion and is provided with the through hole; the two portions are movably connected to each other.

Abstract: A height-adjustable pillow for supporting a patient's head. The pillow includes a casing of flexible material defining a casing volume and a volume of filler material partially occupying in said casing volume. The casing volume is compressible and expandable. The casing volume includes a support portion positioned above a base portion. An air valve is associated with the casing for introducing air into and evacuating air from said casing volume.

Abstract: A dual-chair assembly is disclosed having a practitioner chair rotatably coupled to a base by an extension arm, the base fixedly attached to a ground surface, and disposed a separation distance from the practitioner chair. The dual-chair assembly also includes a subject chair coupled to and supported by the base. A practitioner control is communicatively coupled to practitioner chair actuators, the practitioner control including a user input interface operably configured for receiving a practitioner input, and, as a result of the practitioner input, causing the practitioner chair actuators to perform at least one of rotating the practitioner chair about the subject chair; adjusting an elevation of the practitioner chair; and rotating at least one of a roll angle, a pitch angle, and a yaw angle of the practitioner chair.

Abstract: In one example, an apparatus for positioning a patient's forearm during a medical procedure has a main panel portion, an extended panel portion and a base panel portion. The main panel portion has an inner surface and an outer surface, a first longitudinal side edge, a second longitudinal side edge, a first latitudinal side edge and a second latitudinal side edge. The extended panel portion has panel portion having a proximal end edge and a distal end edge, and an inner surface, wherein said distal end edge forms an angled configuration with said main panel portion for positioning the patient's left forearm and wrist suitably for receiving an arterial catheter. The base panel portion has a first longitudinal side edge and a second longitudinal side edge, wherein said first longitudinal side edge of said base panel portion extends generally perpendicularly outward from said second longitudinal side edge of said main panel portion.

Abstract: The invention relates to an apparatus for treating a human or animal body by mechanical strokes, wherein an applicator for being placed on the patient's body surface has a basically oblique front area portion in an angle between 30° and 60° to the stroke direction.

Abstract: The invention relates to an apparatus for treating the human or animal body by strokes and an applicator 11 provided for that purpose, having a curved-flat shape with a concave and a convex lateral face.

Abstract: Embodiments of the invention can mitigate motion sickness by disrupting, controlling, or influencing anatomy of the vestibular system, including, for example, otoliths, endolymph, and hair follicles. An embodiment of the invention may induce vibrations in the vestibular system, including otoliths and/or semicircular canals of the inner ear, thereby causing noisy or unreliable sensory information in signals sent to the brain from the vestibular system. Due to this noisy or unreliable sensory information, the brain, as part of a normal physiological response, may rely less on signals received from vestibular system and rely more heavily on other sources, thereby mitigating the motion sickness response, vertigo, vestibular migraines, and other physiological responses to inconsistent sensory information. Vibrations in the vestibular system may be induced by an agitator placed on an individual's head near the vestibular system.

Abstract: An edema therapy apparatus for the treatment and therapy of such conditions as edema, lymphedema, clotting and thrombosis. Apparatus is characterized by flexible wrap containing a plurality of vibration motors housed within a corresponding plurality of vibration motors mounts, all of which integrate into wrap. Vibration motors are inserted into vibration motor mounts allowing transfer of vibration from the motors themselves to the applied area. Vibration motors are connected by a wired circuit, which is coupled to a barrel plug adapter at an opposing end of the apparatus. Power is to be applied to the circuit containing the motors by a portable power supply housing a plurality of batteries to supply voltage. Function is control by way of an on-off switch located on the power supply.

Abstract: A containment system for packaging a plurality of products that are to be accessed in a predetermined sequence. The containment system includes a plurality of product compartments that each holds at least one of the plurality of products. Indicators having a gas reactive material that changes appearance after a predetermined period of time of exposure to ambient air are deployed when gas cover seals are removed or broken to access a product in the product compartment.

Abstract: An automated system (100) for compounding pharmaceutical agents for injection treatment of a patient includes a housing (110) enclosing an interior space; an inventory structure (130) having a plurality of chambers (131) for individually holding one or more pharmaceutical agent—containing single use capsules (102), wherein each capsule has a volume capacity of from about 0.1 to about 10.0 mL liquid; means (140) for selecting capsules in accordance with predetermined pharmaceutical agents contained in said capsules; means (150) for moving the selected capsules to a processing area; means (165,166) for sequentially transferring a controlled quantity of the predetermined pharmaceutical agent with direct fluid communication from each selected capsule to a product container under positive or negative pressure; and means (151) for automatically discarding spent capsules from which the pharmaceutical agents have been removed after a single use.

Abstract: A dosing station for a capsule filling machine comprises a dosing unit in which capsule lower parts are filled with a filling material via a filling apparatus and a drive unit with at least one drive that drives at least one component of the dosing unit. The drive unit is arranged beneath a supporting plate, and detachable fastening and coupling means detachably fastens the dosing unit on the supporting plate. Where the dosing unit is detachably fastened on the supporting plate, the at least one drive is coupled to the at least one component. In the detached state of the dosing unit from the supporting plate, the coupling of the at least one drive to the at least one component is canceled. In this way, the dosing unit can be removed as a module from the dosing station.

Abstract: Modular automated dispensing systems for dispensing secured medications in a medical environment are provided. The system includes a compact enclosure configured to be disposed in a medical treatment area without taking up valuable floor space. The system includes lockable drawers having one or more compartments for storing and dispensing medications or medical supplies. The system is unlocked by use of an access control interface internally or externally connected directly to the system, or networked to the system through a medical center network.

Abstract: The present invention relates to a medication tray comprising a plurality a sealed vessels comprising one or more doses of a medicament; a plurality of individually spaced compartments that are adapted to receive the individually sealed vessels; and means for releasably retaining said sealed vessels within said compartments. The tray further comprises a detection means adapted to detect and monitor when individual vessel are dispensed from the compartments of the tray.

Abstract: In an embodiment, a system including a closure device, the closure device including an opening for providing fluid communication there through, an outflow component configured to be disposed over the closure device, the outflow component including an outflow aperture to provide fluid communication between the outflow component and a user, and a securing member for supporting the outflow component in a position over the closure device is provided. The system further includes a stopper component removably engageable with the opening of the closure device, wherein when the stopper component is engaged with the opening, the stopper component obstructs the opening preventing a flow of fluid through the opening, and wherein displacement of the stopper component from the opening allows fluid communication through the opening.

Abstract: A stackable baby bottle assembly with a nestable cap comprises a bottle base, a ring, a nipple, a cap, and, optionally, a sieve. The bottle base includes a plurality of edge members. A plurality of bottle bases may be stacked for storage. When a plurality of bottle bases are stacked, the edge members form space between the bottle bases, thereby permitting air to flow between the bottle bases. The bottle base and cap may include nesting regions, such that the cap may be inverted and snapped onto place onto the bottom of the bottle base, which may be convenient during feeding. A plurality of caps may be stacked for storage.

Abstract: The present invention relates to a baby product, and more particularly to an auxiliary bottle feeding apparatus and a baby product to which the auxiliary bottle feeding apparatus is mounted, which are conceived to perform bottle feeding even without assistance of a guardian while taking care of a baby, and serve as a means for making the face of a baby seated in a bottle feeding posture on the baby product and a pacifier of a baby bottle located on a space to face each other while being spaced apart from each other by a predetermined interval, and consistently fixing said state at the same time.

Abstract: Cosmetic facial treatment delivery sheets with both personalized skincare benefit agents and customized iontophoresis micro-current zones are provided for delivering skincare treatments to multiple targeted areas of the skin to treat different concerns of an individual user. The sheets are made by printing skin benefit agents on a dissolvable or non-dissolvable substrate and then printing micro-current generators with power sources in different locations on the substrate. The micro-current generators facilitate delivery of the benefit agents by iontophoresis, or directly affect treatment by delivery of micro-current to the skin.

Abstract: Cosmetic facial treatment delivery sheets with both personalized skincare benefit agents and customized iontophoresis micro-current zones are provided for delivering skincare treatments to multiple targeted areas of the skin to treat different concerns of an individual user. The sheets are made by printing skin benefit agents on a dissolvable or non-dissolvable first substrate and then printing micro-current generators with power sources in different locations on a second substrate. The first substrate and second substrate are assembled to form the delivery sheets. The micro-current generators facilitate delivery of the benefit agents by iontophoresis, or directly affect treatment by delivery of micro-current to the skin.

Abstract: The present invention relates to a topical composition comprising at least one ingredient selected from the group consisting of a sebum control agent, a skin exfoliation agent and/or a collagen enhancing agent and a porous cross-linked polymethylmethacrylate bead having a particle size Dv0 of greater 0.3 ?m, a Dv100 of less than 35 ?m, a Dv50 selected in the range of 6 to 15 ?m and an oil absorption capacity selected in the range of 1.2 cc/g-2.5 cc/g.

Abstract: The present invention relates to a sunscreen composition comprising: a. an aqueous phase; b. an oil phase comprising at least one cosmetically acceptable oil; c. at least one sunscreen active; and d. up to about 5% by weight, based on the total weight of the composition, of an emulsifier system comprising; i. at least one ionic surfactant; ii. at least one nonionic surfactant having an HLB of greater than or equal to about 14; and iii. at least one nonionic surfactant having an HLB of less than or equal to about 10; wherein the composition is an oil-in-water emulsion containing oil droplets having an average particle size of from about 100 to 150 nm, is alcohol-free, and appears semi-transparent to transparent upon application onto an end-user's skin.

Abstract: The invention relates to a cosmetic composition comprising at least an oily phase, the said oily phase comprising at least: (i) a silicone elastomer present in aqueous droplets which are dispersed in said oily phase, (ii) at least one particular surfactant chosen from: —a) silicone surfactants having a chemical structure comprising silicone side chains and hydrophilic side chains, of which the general formula (I) is: (I) —b) silicone surfactants having a chemical structure comprising hydrophilic chains at both ends (?- ?substitution) of the main chain, of general formula (II) below: (II) —c) hydrocarbon-based surfactants resulting from the esterification of a mixture of polyglycerol with (i) a polyhydroxystearic acid, with 2 to 5 polyglycerol units, (ii) linear or branched aliphatic dicarboxylic acids containing 4 to 14 carbon atoms, and (iii) saturated or unsaturated, linear or branched fatty acids containing from 16 to 20 carbon atoms.

Abstract: Provided are a method for searching for a malodor inhibitor by using the response of an olfactory receptor as an indicator; a method for inhibiting malodor based on the antagonism of olfactory receptors; and a malodor inhibitor. Disclosed are a method for searching for a malodor inhibitor, the method including: adding a test substance and a malodor-causing substance to any one olfactory receptor selected from the group consisting of OR51E1, OR2W1, OR10A6, OR51I2, and OR51L1, measuring the response of the olfactory receptor to the malodor-causing substance, identifying the test substance that suppresses the response of the olfactory receptor on the basis of the measured response, and selecting the identified test substance as a malodor inhibitor; an antagonist to any one olfactory receptor selected from the group consisting of OR51E1, OR2W1, OR10A6, OR51I2, and OR51L1; a method for inhibiting malodor using the antagonist.

Abstract: A lotion emulsion composition comprising a preservative enhancing agent and a rheology modifier, wherein the preservative enhancing agent comprises one of sorbitan caprylate, glyceryl caprylate/caprate, or a combination thereof, the rheology modifier comprises a hydrocolloid, the pH of the lotion emulsion composition is less than about 4.2, and the combined amount of preservative enhancing agent and rheology modifier is less than about 0.3% by weight of the total lotion emulsion composition.

Abstract: A deodorant composition comprising arginine, bicarbonate, zinc and carbonate, preferably arginine bicarbonate and zinc carbonate (ABZC), and one or more physiologically acceptable excipients, administered for the modification of cutaneous microfloras—generally to reduce axillary odor, promote the growth of Staphylococcus epidermidis bacteria, inhibit the growth of Corynebacterium striatum bacteria, or any or all of the preceding.

Abstract: A composition for protecting from ultraviolet radiation is disclosed. The composition comprises a filter and an effectiveness indicator responsive to the reduction of effectiveness protection.

Abstract: The present invention relates to antiperspirant and deodorant compositions comprising malodor reduction compositions and methods of making and using such antiperspirant and deodorant compositions. Such antiperspirant and deodorant compositions comprising the malodor control technologies disclosed herein provide malodor control without leaving an undesirable scent and when perfume is used to scent such compositions, such scent is not unduely altered by the malodor control technology.

Abstract: The present invention relates to personal care compositions comprising malodor reduction compositions and methods of making and using such personal care compositions. Such personal care compositions comprising the malodor control technologies disclosed herein provide malodor control without leaving an undesirable scent and when perfume is used to scent such compositions, such scent is not unduly altered by the malodor control technology.

Abstract: A method is provided for identifying a material having an efficacy for reducing color contrast between a hyperpigmented skin lesion and skin surrounding the hyperpigmented skin lesion without directly affecting melanocytes or melanogenesis. The method includes the steps of applying a composition containing a material to be tested to the hyperpigmented skin lesion; and after an interval of time, observing whether the composition has effected at least one of inhibiting proliferation of keratinocytes, stimulating differentiation of keratinocytes, and improving compressive deformation of dermal papillae, in a basal layer of epidermis in the hyperpigmented lesion of skin.

Abstract: Saponin (quillaja and yucca) and terpenoid (mono- and di-) botanicals are used for emulsion-based lipids to produce stable nanoparticles of the active nutrients or pharmaceuticals by reducing surfactant usage (less than 5%) and by reducing particle size (less than 600 nm). Non-synthetic emulsion-based formulations enhance bioavailability and mitigate safety concerns. This nanoemulsion technology is suitable for oil-in-water ingredients including vitamin E tocotrienols, CoQ10s, curcuma terpenoids, symmetrical carotenoids, phenolics, lipid-soluble vitamins, and lipid-soluble pharmaceuticals.

Abstract: The present invention provides an antiperspirant composition comprising at least 3.5% by weight of zinc phenolsulphonate or zinc lactate, wherein said composition is substantially free of aluminum salts.

Abstract: The present invention relates to cleansing compositions including: (a) from about 3% to about 20% by weight based on the total weight of the composition amphoteric surfactant; and (b) an alkyl glucoside surfactant, wherein a ratio of alkyl glucoside surfactant to amphoteric surfactant is at least 1 to 1, the composition is free of ethoxylated surfactants, and the composition has a viscosity of at least 1000 centipoise.

Abstract: A skin smoothing composition that has from about 0.5 to about 10%, by weight, of an interpenetrating polymer that is a co-polymer of polyurethane and a polyacrylic polymer. The composition further contains from about 0.1% to about 5%, by weight, of a thickener made from homopolymers of acrylic acid crosslinked with a cross linker selected from the group consisting of an allyl ether pentaerythritol, allyl ether of sucrose, allyl ether of propylene and mixtures thereof. And from about 10 to 98% water.

Abstract: A method for improving the condition of skin by following the steps of applying a first composition that has from about 0.5 to about 10%, by weight, of an interpenetrating polymer that is a co-polymer of polyurethane and a polyacrylic polymer. The first composition further contains from about 0.1% to about 5%, by weight, of a thickener made from homopolymers of acrylic acid crosslinked with a cross linker selected from the group consisting of an allyl ether pentaerythritol, allyl ether of sucrose, allyl ether of propylene and mixtures thereof, and from about 10 to 98% water. The next step is applying a second composition that is in a form of an aqueous solution, an organic solvent solution, an oil based solution, an emulsion, a suspension, an aqueous gel, an oil-in-water emulsion, a water-in-oil emulsion, a thickened aqueous gel, a thickened oil phase, an encapsulated oil phase, a solid oil phase, an aqueous solution comprising a plasticizer, and mixtures thereof.

Abstract: A soap composition for the treatment of skin conditions and irritations, including 40-50 wt % soy oil, 15-25 wt % coconut oil, 1-10 wt % olive oil, 0.5-5 wt % cocoa butter, 15-25 wt % water, and 5-15 wt % sodium hydroxide. A lotion composition, including 85-99 wt % lotion base, 2-10% neem oil, and 0.5-5% black seed oil. A lip balm composition, including 80-99.999 wt % lip balm base, and 0.001-20 wt % of a composition of castor oil, palm kernel oil, aloe extract, carnauba wax, candelilla wax, cocoa butter, vanilla oil, vanilla, and combinations thereof. A method of treating a skin irritation by applying the soap composition to skin, and relieving the irritation. A method of making a soap composition. A method of treating a skin irritation by applying the lotion composition to skin, and relieving the irritation.

Abstract: A composition comprising an odor-suppressing mixture including parsley, alfalfa, oregano, and wheatgrass that cures halitosis. The odor-suppressing mixture comprises at least 50 weight percent of the composition. The composition is devoid of artificial preservatives, alcohol, sodium, sucrose and artificial sugar substitutes, and the odor-suppressing mixture may include the additional ingredients mint, spearmint, or thyme. A beverage is made from this composition.

Abstract: Methods of using WIPI-1 to impart anti-aging benefits to the skin and/or improve skin conditions resulting from reduced autophagy activity.

Abstract: The invention features sublingual formulations of apomorphine and apomorphine prodrugs, and methods of treating Parkinson's disease, sexual dysfunction, and depressive disorders therewith.

Abstract: The present invention provides methods and kits for preventing, treating or delaying various cardiovascular diseases or disorders especially heart failure by extended release of neuregulin to a mammal. Moreover, the extended release of neuregulin is administered by subcutaneous infusion with a pump.

Abstract: Dry powder vancomycin compositions and methods for administering and preparing such compositions are provided.

Abstract: The present invention provides methods and taste-modifying kits for facilitating cleansing of the gastrointestinal tract of a patient prior to a diagnostic, surgical or therapeutic procedure. The methods and taste-modifying kits can improve patient compliance, and thus, efficacy of the preparation. Specifically, the present methods make the gastrointestinal tract preparation composition palatable for the patient to consume. For example, for a patient preparing to undergo colonoscopy, the present methods make the bowel preparation solution taste significantly less salty.

Abstract: This invention relates to a gel-like composition in which ubiquinol is dispersed and stabilized in a gel and which contains 0.2 to 5% by weight of ubiquinol, 5 to 15% by weight of gelatin, 55 to 80% by weight of carbohydrate and/or water-soluble dietary fiber, and 9 to 18% by weight of water, and further contains ascorbic acid and/or gallate type catechin.

Abstract: Provided is a foam-forming formulation and method of treating an infection in a body cavity. The foam-forming formulation contains hydrogen peroxide, monoglyceride crystals, at least one acid and/or buffer which is present in an amount to provide a pH of 3 to 5 within a body cavity, a blowing agent in an amount to blow the foam-forming composition and form a foam, and water. The foam-forming composition is suitable application to body cavity when blown to form the foam and the form degrades at a body temperature to release the hydrogen peroxide to tissues in the body cavity at a pH of 3 to 5. Also provided is a foam-forming composition vehicle for delivering an active agent.

Abstract: Provided are porous metal oxide particles, in which 50% mean particle size by volume is equal to or larger than 50 nm and equal to or smaller than 300 nm, ratio of 90% mean particle size by volume to 50% mean particle size by volume (D90/D50) is equal to or lower than 2.0, the particles have mesopores having a pore size determined by BJH method of equal to or larger than 5 nm and equal to or smaller than 30 nm, and the structure of the pores is a three-dimensional cubic phase structure.